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Abstract
Background: Chickenpox vaccine is not included in the routine childhood vaccination programme in Sweden.
The aim of this study was to estimate the baseline of national chickenpox disease burden, as comprehensive
studies, required for an assessment regarding vaccine introduction, are lacking.
Methods: We used available health care registers and databases; the death register, hospitalisations register,
communicable disease notifications database, Stockholm County registers on consultations in specialist and
primary care, temporary parental benefit to care for a sick child, and searches on the health care system’s
website.
From each data source, records regarding chickenpox were identified and extracted, either using relevant
diagnosis codes (ICD-10) or key words. A descriptive analysis with regards to number of cases and incidence,
severity, and seasonality, was carried out covering the time period 2007 to 2013.
Results: There were on average 333 patients hospitalised annually due to chickenpox, yielding a
hospitalisation rate of 3.56/100,000 person-years. We found a slight male predominance in hospitalised cases.
The highest hospitalisation rate was seen in 1 year-olds, whereas the peak in primary care consultations was
in 2 year-olds. Nearly a quarter of children had parents who reported absence from work to care for them
when sick with chickenpox. The average yearly death rate from chickenpox was 0.034/100,000 person-years.
The duration of hospital stay increased with age. The seasonality in number of searches on the health care
website corresponded well with hospitalisations and primary care consultations with peaks in spring.
Conclusions: This study shows chickenpox death and hospitalisation rates in range with other European
countries without routine vaccination. Swedish children fall ill with chickenpox at a very young age.
The study provides essential input for future discussions on the introduction of routine chickenpox
vaccination in Sweden.
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Background
The varicella zoster virus (VZV), a herpesvirus with hu-
man as only known reservoir, is easily transmitted and
thus, most people are infected already in childhood.
VZV causes two distinct diseases; the primary manifest-
ation chickenpox (varicella) is followed by life-long virus
latency in the nervous system’s dorsal root ganglia and
when reactivated can present with shingles (herpes
zoster). The present study focuses on chickenpox, a
well-known fever and rash illness. Chickenpox is gener-
ally considered a mild disease of children and most cases
will not seek medical attention. However, severe compli-
cations are seen both among child and adult cases;
mainly neurological involvement and secondary bacterial
infections. The risk for severe disease increases with age
but is also elevated in infants and the immunosup-
pressed [1, 2].
Since next to everybody acquires chickenpox in West-
ern countries, the yearly incidence is approximately one
birth cohort. However, the epidemiology varies between
countries, even within Europe. Hospitalisation rates do
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not look entirely the same in register-based studies.
Further, seroepidemiological studies show differences
in age of infection with children acquiring antibodies
earlier in Northern and Western Europe compared to
Southern and Eastern, often explained by differences
in child care. This leaves discrepancies in the percent-
age of the young adult population who are still sero-
negative [3, 4].
There are vaccines against chickenpox; currently all
are live attenuated vaccines, considered safe and effect-
ive. Chickenpox vaccine is not included in the routine
childhood vaccination programme in Sweden. In coun-
tries where it is, it has had a dramatic effect on disease
burden. Both the World Health Organization (WHO)
and the European Centre for Disease Prevention and
Control (ECDC) acknowledge a favourable impact of
routine vaccination as long as high coverage can be
achieved [2, 3]. Further, they encourage countries to set
up varicella surveillance and assess the epidemiology be-
fore deciding on or implementing routine vaccination,
since the epidemiology will influence the need of a
programme and should have bearing on its design and
in the continuation its cost-effectiveness. In Sweden,
there is no such up-to-date information on the epidemi-
ology. Neither chickenpox nor shingles are notifiable
diseases, except for their severe complication meningo-
encephalitis. In recent years, several studies on the na-
tional disease burden of shingles have been presented
[5–7], whereas the national burden of chickenpox dis-
ease has only sporadically been assessed. In a seroepide-
miological study using blood samples from 1997, Svahn
et al. found approximately 98 % of 12 year-olds to be
seropositive [8]. In a register-based assessment, Linde et
al. found 322 children and 154 youths and adults were
hospitalised in 1993 in Sweden due to chickenpox [9].
Grimheden et al. showed that the hospitalisation rate
among Stockholm children was 1.6/1,000 chickenpox
cases in 1998–2005 and only a minority (28 %) of these
children had any underlying illness [10].
Methods
In this retrospective study we used available data from a
range of established health care registers and databases
to make a comprehensive assessment of the chickenpox
disease burden in Sweden in recent years.
Only data concerning chickenpox were extracted. To
identify chickenpox-related records, we used either rele-
vant key words or ICD-10 codes (International Statistical
Classification of Diseases and Related Health Problems -
Tenth Revision); B01.0 Chickenpox with meningitis,
B01.1 Chickenpox encephalitis, B01.2 Chickenpox with
pneumonia, B01.8 Chickenpox with other specified com-
plications and B01.9 Chickenpox without complications.
Data sources and data extraction
Deaths
The Cause of Death Register is kept by the National
Board of Health and Welfare and holds data on causes
of death for all Swedish citizens deceased in Sweden or
abroad. Relevant records of chickenpox-related deaths
were identified using ICD-10 codes.
Hospitalisations
The National Patient Register, also kept by the National
Board of Health and Welfare, holds data on all hospital
inpatient care. Reporting of hospitalisations are
mandatory by law and the register has 99 % complete-
ness. An evaluation has also shown high validity of the
register [11]. Chickenpox-related records for this study
were identified using the relevant ICD-10 codes; both re-
cords with chickenpox as primary and secondary diagno-
sis were extracted. Data on gender, age (in years) and
relevant dates were extracted.
Consultations in specialist and primary care
Data on consultations in specialist and primary care
were not available for the entire country.
The Stockholm Health Care Databases kept by the
Stockholm County Council hold the same data as the
National Patient Register, but restricted to hospitalisa-
tions within Stockholm County (≈2 million population).
In addition, the registers hold data on consultations in
specialist and primary care in the county (85–95 %
coverage, personal communication Gunnar Ljunggren,
Stockholm County Council). The same inclusion criteria
and variables as above were used.
Notifications
The SmiNet2 database at the Public Health Agency
holds notifications of communicable diseases. Cases with
viral meningoencephalitis whose cerebrospinal fluid was
found PCR-positive for virus or where intrathecal anti-
body production was detected, fall under mandatory
reporting from both the diagnosing laboratory and the
diagnosing doctor. The notification forms hold informa-
tion on the relevant virus, age, gender and - with poor
completeness - the clinical presentation, i.e. in this case
whether the VZV-meningoencephalitis was related to
chickenpox or to shingles.
Web searches
A project based at the Public Health Agency [12] has
continuous access to anonymous free text searches on
the health care system’s website (http://www.1177.se)
and has previously been used for e.g. influenza surveil-
lance. In this study, search terms including varicella,
chickenpox, and “vattkoppor” (chickenpox in Swedish),
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along with various misspelt versions of these words were
monitored.
This data source was included mainly with the object-
ive to capture variations over time, as it was assumed to
be timely and have high sensitivity to capture changes in
incidence.
Temporary parental benefit when caring for sick child (VAB)
Through collaboration with the Swedish Social Insur-
ance Agency, data on cause and length of parents’ ab-
sence from work to care for sick child were collected.
Parents need to report VAB to the Social Insurance
Agency on the first day of their absence from work
in order to receive the temporary benefit. Symptoms
of the child are probed for in the reporting form by a
set of alternatives, including chickenpox. Recognition
of this disease among Swedish parents has been
shown to be high [13].
This data source was assumed to register a larger
proportion of cases than the sources described above,
as it captures also mild cases not seen by the health
care system. Data was delivered aggregated on year.
We included reports on children of 14 years and
below.
Population data
Data on yearly average age-specific population size (age
during the year) were taken from the website of Statis-
tics Sweden (http://www.scb.se).
Study period
For each register/database we used data from as early as
possible after January 2007 until as late as available. The
period of available data differed somewhat between reg-
isters, but there was good overlap. From the health care
registers the latest available data were extracted, i.e. the
six year period January 2007 to December 2012. For the
other data sources, all available data were included. Data
on web searches and high quality data on VAB could
only be retrieved for 2011–2013. We used notification
data from 2007–2013.
Data analysis plan
The entire analysis only included chickenpox-related re-
cords, as described above.
The majority of cases were children and data were
analysed for each year of age separately from 0 to 9 years.
Adolescents and adults were analysed by age groups:
10–14 years, 15–24 years, 25–44 years, 45–64 years, and
65 years and above.
For cases with more than one health care contact, only
the first hospitalisation, consultation in specialist or in
primary care was used in relevant analyses.
All register data were taken at face value, no correc-
tions or consistency checks were carried out. The ration-
ale behind this was that if these data sources would
constitute a basis for future routine chickenpox surveil-
lance, limited time and resources would be available for
data cleaning and management.
Data were analysed with regards to the three aspects;
number of cases and incidence, severity, and seasonality.
Number of cases and incidence
We carried out a descriptive analysis of number of
chickenpox cases and events, i.e. deaths, hospitalisations
or consultations in specialist or primary health care
(only for Stockholm County), overall and by age and
gender, as well as the overall and age-specific incidence.
Results are presented both for cases that had chickenpox
as primary diagnosis and diagnosis in any position.
We investigated the number of chickenpox-afflicted
children whose parents were absent from work and the
age distribution of these children, the overall, age-
specific and cumulative incidence.
Severity
The separate data sources capture a range of severity
levels of disease; fatal cases and cases with notified men-
ingoencephalitis were defined to represent severe
disease.
Severity was also assessed by looking at complications
according to the ICD-10 codes among hospitalised pa-
tients as well as length of hospital stay and VAB. The
number of VAB days are presented as gross days (i.e. cal-
endar days) the parents were absent from work.
Seasonality
The numbers of chickenpox cases by month by data
source were described in a time-serie in order to explore
seasonality. Periodograms were used to further investi-
gate the seasonal pattern.
The correlation between monthly numbers of web
searches and numbers of cases by the other data sources
were analysed with negative binomial regression adjust-
ing for number of web searches in previous months
(lags).
Results
Number of cases and incidence
From 2007 to 2012 there were annually between 280
and 386 cases hospitalised with chickenpox in Sweden,
with an average of 333 patients, or an average hospital-
isation rate of 3.56/100,000 person-years. As some pa-
tients were admitted on several occasions, these patients
yielded a total 377 hospitalisations and 1,740 hospital
days per year. In addition, the incidence of making at
least one consultation in specialist care was 20.1
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patients/100,000 person-years and in primary care 109
patients/100,000 person-years, based on Stockholm
County data (Table 1).
The median age was 4 years among hospitalised cases
and 3 years among those consulting any type of out-
patient care. The peak incidence of hospitalisations was
among 1 year-olds, and among 0 year-olds for consulta-
tions in specialist care. The VAB peak was among par-
ents of 2 year-olds and also the peak of primary care
visits in Stockholm was among 2 year-olds (Table 2).
Over the six year period, 55 % of hospitalised cases and
52 % of patients consulting in both specialist and primary
care, were male. There was no statistically significant dif-
ference in the gender distribution over the age groups (p
= 0.31, p = 0.28 and p = 0.59, respectively).
Cumulative incidence of chickenpox-related VAB –
regardless of length of VAB - reached nearly to a
quarter (23,196/100,000 person-years) of children
below 15 years in Sweden.
Severity
Over the 6 year period there was an average of 3.2
deaths/year (mortality rate 0.034/100,000 person-years),
with a total of 19 deaths where chickenpox was contrib-
uting (n = 7) or underlying cause (n = 12). Chickenpox
was not stated as the primary cause of death in any of
the records. There was wide variation in primary cause
of deaths and no interpretation as to its relation to the
chickenpox illness can be made. The range of yearly
deaths was 1 to 5 and the age range 1 to 91 years, with a
median age of 58 years. Seven people were below
15 years. Among children 4 of 7 (57 %) deaths were girls
and among adults 5 of 12 (42 %) were women.
The highest notification rate for VZV-meningoencephalitis
was seen in the older age groups. For children below
10 years the incidence was less than 0.5 cases/100,000
person-years, whereas in all age groups above 10 years
the incidence was greater than 0.5. During 2007–2013,
clinical data were only reported for 146 of 686 notified
cases (21 %). Of those 54 % lacked information on
presence of rash and thus, making it difficult to dif-
ferentiate between chickenpox and shingles as the
cause of meningoencephalitis.
The percentage of admitted patients with ICD-10
codes indicating chickenpox with complications also
increased slightly with age (p = 0.001). Chickenpox
with encephalitis or meningitis was more frequent
among adult cases, whereas other specified compli-
cations (B01.8) were seen more among the children
(Fig. 1). The length of hospital stay increased with
age (p < 0.001) (Table 2), whereas the length of VAB
was similar for children of all ages, around
3.5 days.
Seasonality
Chickenpox-related web searches, hospitalisations, and
consultations in primary care (Stockholm County only)
all showed a yearly pattern in the periodograms. As seen
in Fig. 2, there were high numbers of cases during win-
ters to spring. The lowest numbers were seen in August
or September of each year. The seasonality pattern was
mainly observed among young cases; no seasonal vari-
ation could be observed in the number of admitted
adults above 45 years of age.
The number of web searches were associated with
number of hospitalisations in the same month and with
Table 1 Average yearly number of cases and average incidence of chickenpox in Sweden
Primary diagnosis Primary or secondary diagnosis
(n) (per 100,000 pop.) (n) (per 100,000 pop.)
Deathsa 0 0 3.2 0.034
Hospitalisationsa 256 2.74 378 4.04
Hospitalised patientsa 236 2.52 333 3.56
Hospital daysa 979 1740
Consultations in specialist careb 19.7 22.9
Consultations at least once in specialist careb 17.6 20.1
Consultations in primary careb 112 118
Consultations at least once in primary careb 104 109
Parents absence from work to care for sick child,
VAB gross daysc
98730
VAB number of childrenc 26072 1631
a2007–2012, national data
b2007–2012, Stockholm County data, only incidence reported for comparability
c2011–2013, national data
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numbers of consultations in primary care in Stockholm
in the same and the previous month.
Discussion
This study was constructed to provide a baseline for
chickenpox disease in Sweden before a decision regard-
ing national routine vaccination.
Very few people died of the disease (0.034/100,000
person-years). The overall hospitalisation rate in
Sweden over the study period (3.56/100,000 person-
years) was in range with findings in other European
countries without routine varicella vaccination, e.g.
the Netherlands and Belgium, as well as Italy and
Spain in the pre-vaccination era (1.9–8.9/100,000
person-years) [14–18]. With an assumed birth cohort
(approximately 110,000) of chickenpox cases annually
this rate corresponds to 3 hospitalisations/1,000 cases.
The hospitalisation rate for ≤14 year-olds (15.3/
100,000 person-years) was also comparable to inter-
national findings [17, 19], except for a higher rate in
France [20].
We were anticipating a young age of infection in
Sweden; high child care attendance from a young age
has been correlated to early acquisition of chickenpox
[4] and Swedish children have high participation rates in
pre-school, over 85 % already at 2 years of age (the
Swedish National Agency for Education, http://
www.skolverket.se). We did find a majority of cases in
children 5 years or below (58 % of all hospitalised cases),
which is more than e.g. in Spain pre-vaccination [18].
There was a slight male predominance among hospita-
lised cases, also described elsewhere [19, 21].
Table 2 Average yearly number of hospitalised chickenpox cases, average length of hospital stay and average incidence of chickenpox-








consultation rate a, b
Primary care
consultation rate a, b
Parents absence from work to
care for sick child, VAB rate a , c
0 40.2 36.1 3.7 262 376 18
1 45.3 41.0 3.0 221 1204 3246
2 36.0 32.8 3.7 182 1325 4615
3 29.5 27.3 4.3 142 1146 4198
4 22.7 21.3 3.3 106 938 3861
5 20.8 19.8 3.9 87.0 708 2967
6 11.0 10.6 4.2 53.6 493 1922
7 10.3 10.3 9.3 38.0 305 1123
8 5.2 5.1 10.2 22.1 199 644
9 4.3 4.4 20.6d 23.1 137 333
10–14 13.3 2.6 3.9 11.9 70.8 54.9
15–24 18.5 1.5 8.2d 8.8 34.7
25–44 37.0 1.5 3.2 8.5 28.6
45–64 18.2 0.8 11.0 1.5 8.1
65+ 20.3 1.2 11.4 1.7 4.4
Total 333 3.56 5.1 20.1 109
Total children
(≤14 years)
239 15.3 4.3 87.6 518 1631
a per 100,000 person-years in population of the same age
b Stockholm County only
c 2011-2013
d one patient hospitalised for more than one year, according to record
Fig. 1 Frequencies of ICD-10 codes for chickenpox and its
complications, by age group, among hospitalised chickenpox
cases with a B01.x diagnosis in Sweden, 2007–2012
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The incidence of consulting specialist or primary care
was 20.1 and 109 cases/100,000 person-years, respect-
ively. The consultation rate in primary care was less than
half of those in other countries [14–16], which is also
seen in overall national comparisons and possibly ex-
plained by health care organization [22].
In previous studies [14, 18–21] the highest chickenpox
hospitalisation rates were seen in children below 1 year
(range: 39.2-149/100,000 person-years). Infants are
known to have a more severe disease, they might also be
admitted more generously than older children. Hospital-
isation rates for 1–4 year-olds was slightly lower (30.7/
100,000 person-years in our material) than in infants,
similarly to other countries. However, when we split up
this age group into yearly intervals we found the true
peak hospitalisation rate in 1 year-olds (41/100,000
person-years) (Table 2). A Belgian study that did not
group the youngest children also found a peak in 1 year-
olds [16] and a Dutch study showed a peak in General
Practitioner consultations in 1 year-olds [15]. It seems
important that studies on age distribution of chickenpox
report their findings for the youngest children in suffi-
cient detail.
Increasing age is a known risk factor for severe
chickenpox disease. In this study we found longer hos-
pital stays and a somewhat larger proportion of ICD-10
codes for complicated chickenpox disease with increas-
ing age. Also, the median age was slightly higher in hos-
pitalised cases than patients seen in outpatient care,
implying a higher age among severe cases.
Data from health care registers provide information on
severe cases, which unquestionably are those a vaccin-
ation programme sets out to prevent and thereby are
most important to monitor. However, in order to accur-
ately describe the epidemiology, also mild cases need to
be defined. Since age is an important risk factor for se-
vere chickenpox disease it cannot be assumed that the
age distribution of mild and severe cases look the same.
We found most cases of severe disease in the young
ages, where the complication rate is known to be at its
lowest [23]. Thus, we suspect that a majority of chicken-
pox cases, also mild cases, fall ill at this early age. This is
a desirable equilibrium when this disease is present and
needs to be taken into account when assessing a vaccin-
ation programme. The best method to more precisely
describe the age-specific incidence and capture also
those who have had a mild disease and to determine the
immunity in the population is a seroepidemiological
study. Since this is a laborious, costly and also ethically
sensitive issue as it involves drawing blood from healthy
children, such a study has not been carried out for
nearly two decades in Sweden. Instead we used a proxy
for mild disease; temporary parental benefit when caring
for a child sick with chickenpox. In fact, parents of more
than 23 % of Swedish children were found here, i.e. one
quarter of all children below 15 years have had a parent
staying home from work because of chickenpox in the
child. However, there were some data limitations; al-
though a majority of parents were likely to be employed
and fall under mandatory reporting of absence from
Fig. 2 Number of chickenpox-related web searches, consultations in primary care (only Stockholm County) and hospitalisations, by month, in Sweden
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work when caring for a sick child, reporting of the
child’s symptoms/disease is not mandatory and there
might be loss of information. Furthermore, there is no
need to report sickness of child during the first
18 months of parental leave before a child starts day care
and the data are truncated at around that age. Addition-
ally, if a parent is on the 18 months parental leave for a
younger sibling when an older sibling falls ill, there is no
need for additional reporting of absence from work. Yet,
parental benefit is a rather unique data source and the
best we can do at the current time to define the age dis-
tribution of mild cases. Considering the limitations men-
tioned, the true peak incidence of mild disease should
not be older than the 2 years found here; corroborating
our assumptions of a young age of infection in Sweden.
This data source also gives us an indication of the dur-
ation of disease in children (i.e. an average parental ab-
sence of 3.5 days).
Another way to capture mild disease was to include
chickenpox-related searches on the health care system’s
website. The main objective was to catch changes in sea-
sonality. As previously described for chickenpox, the
peak incidence was in the late winter to spring [24]. Sea-
sonal variations are only seen for children, adult cases
were fewer and more sporadic. There was strong correl-
ation between the monthly number of web searches and
the number of hospitalisations and consultations in pri-
mary care, respectively. Thus, monitoring of chickenpox
web searches gives accurate information on the circula-
tion of chickenpox without any reporting delay.
This study only captures cases with a record of
chickenpox disease. Cases with late complications might
be underestimated; e.g. there is increasing evidence of an
elevated risk of stroke and other cerebrovascular insults
in the wake of a chickenpox infection [25]. Even though,
these complications are rare, the severity of each case
will make a considerable impact on disease burden.
Except for taking all data at face value, without any
validity checks, the accuracy of our results could be in-
fluenced by people getting chickenpox vaccination in the
absence of routine vaccination. A number of people
choose to get the vaccination at their own cost and in
addition, susceptibles in the immediate family of particu-
larly sensitive/ immunosuppressed patients are vacci-
nated against e.g. chickenpox (cocooning). In total
roughly 1,000 chickenpox vaccinations are given yearly
in Sweden (according to prescriptions in the Concise
database), i.e. less than 1 % of a birth cohort or less than
0.5 % if two doses are given, which could not affect the
results in any substantial way.
Conclusion
The burden of chickenpox disease in Sweden is not neg-
ligible; the disease is common and sometimes severe.
Swedish children fall ill with chickenpox at an early age.
This study provides a baseline for the national disease
burden and should serve as input for future discussions
on the introduction of routine vaccination. The main
limitation with these data is the difficulty in attaining re-
liable mild disease estimates.
Acknowledgements
We would like to thank Tiia Lepp, Anette Hulth and Jenny Hellman at the
Public Health Agency of Sweden, Andrea Kolk and Fanny Jatko at the
Swedish Social Insurance Agency and Gunnar Ljunggren at Stockholm
County Council for their help in the provision of data.
Funding
This work was not supported by any external funding.
Availability of data and materials
The datasets supporting the findings in this study are available from the
holders of each health care register/database. The authors have not got the
right to publish the datasets in their entirety.
Authors’ contributions
Study conception and design: KW, JG, AT, LL. Acquisition of data: KW.
Analysis of data: KW. Drafting of manuscript: KW Critical revision: KW, JG, AT,
LL. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Ethical approval for the study was obtained from the Stockholm Ethical
Review Board (2014/584-31/1). Consent to participate was not applicable as
only anonymized register data was used.
Author details
1Department of Medicine, Huddinge, Karolinska Institutet, Stockholm,
Sweden. 2Department of Monitoring and Evaluation, The Public Health
Agency of Sweden, Solna, Sweden. 3Department of Medical Epidemiology
and Biostatistics, Karolinska Institutet, Stockholm, Sweden. 4Department of
Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
Received: 26 March 2016 Accepted: 25 October 2016
References
1. Heininger U, Seward JF. Varicella. Lancet. 2006;368(9544):1365–76.
2. World Health Organization. Varicella and herpes zoster: WHO position paper,
June 2014. 2014. http://www.who.int/wer/2014/wer8925.pdf?ua=1.
3. European Centre for Disease Prevention and Control Varicella vaccination in
the European Union. ECDC Guidance: 2015. http://www.ecdc.europa.eu/en/
publications/Publications/Varicella-Guidance-2015.pdf.
4. Nardone A, de Ory F, Carton M, Cohen D, van Damme P, Davidkin I, et al.
The comparative sero-epidemiology of varicella zoster virus in 11 countries
in the European region. Vaccine. 2007;25(45):7866–72.
5. Studahl M, Petzold M, Cassel T. Disease burden of herpes zoster in Sweden–
predominance in the elderly and in women - a register based study. BMC
Infect Dis. 2013;13:586.
6. Sundstrom K, Weibull CE, Soderberg-Lofdal K, Bergstrom T, Sparen P,
Arnheim-Dahlstrom L. Incidence of herpes zoster and associated
events including stroke–a population-based cohort study. BMC Infect
Dis. 2015;15:488.
7. Nilsson J, Cassel T, Lindquist L. Burden of herpes zoster and post-herpetic
neuralgia in Sweden. BMC Infect Dis. 2015;15:215.
8. Svahn A, Berggren J, Parke A, Storsaeter J, Thorstensson R, Linde A. Changes
in seroprevalence to four herpesviruses over 30 years in Swedish children
aged 9–12 years. J Clin Virol. 2006;37(2):118–23.
Widgren et al. BMC Infectious Diseases  (2016) 16:666 Page 7 of 8
9. Linde A, Lindberg A. [Should more people be vaccinated against varicella?
Time to decide!]. Lakartidningen. 1997;94(14):1296. 9–301.
10. Grimheden P, Bennet R, Hjern A, Nilsson A, Eriksson M. Chickenpox not
always a harmless child disease. General vaccination in Sweden can prevent
significant morbidity. Lakartidningen. 2009;106(9):580–2.
11. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C,
et al. External review and validation of the Swedish national inpatient
register. BMC Public Health. 2011;11:450.
12. Hulth A, Rydevik G. GET WELL: an automated surveillance system for
gaining new epidemiological knowledge. BMC Public Health. 2011;11:252.
13. Parment PA, Svahn A, Ruden U, Brakenhielm G, Storsaeter J, Akesson L, et al.
Immunogenicity and reactogenicity of a single dose of live attenuated varicella
vaccine and a booster dose of measles-mumps-rubella vaccine given
concomitantly at 12 years of age. Scand J Infect Dis. 2003;35(10):736–42.
14. de Melker H, Berbers G, Hahne S, Rumke H, van den Hof S, de Wit A, et al. The
epidemiology of varicella and herpes zoster in The Netherlands: implications
for varicella zoster virus vaccination. Vaccine. 2006;24(18):3946–52.
15. van Lier A, van Erp J, Donker GA, van der Maas NA, Sturkenboom MC, de
Melker HE. Low varicella-related consultation rate in the Netherlands in
primary care data. Vaccine. 2014;32(28):3517–24.
16. Bilcke J, Ogunjimi B, Marais C, de Smet F, Callens M, Callaert K, et al. The
health and economic burden of chickenpox and herpes zoster in Belgium.
Epidemiol Infect. 2012;140(11):2096–109.
17. Pozza F, Piovesan C, Russo F, Bella A, Pezzotti P, Emberti GL. Impact of
universal vaccination on the epidemiology of varicella in Veneto, Italy.
Vaccine. 2011;29(51):9480–7.
18. Gil A, San-Martin M, Carrasco P, Gonzalez A. Epidemiology of severe
varicella-zoster virus infection in Spain. Vaccine. 2004;22(29–30):3947–51.
19. Liese JG, Grote V, Rosenfeld E, Fischer R, Belohradsky BH, v Kries R. The
burden of varicella complications before the introduction of routine
varicella vaccination in Germany. Pediatr Infect Dis J. 2008;27(2):119–24.
20. Dubos F, Grandbastien B, Hue V, Hospital Network for Evaluating
Management of Common Childhood D, Martinot A. Epidemiology of
hospital admissions for paediatric varicella infections: a one-year prospective
survey in the pre-vaccine era. Epidemiol Infect. 2007;135(1):131–8.
21. Theodoridou M, Laina I, Hadjichristodoulou C, Syriopoulou V. Varicella-
related complications and hospitalisations in a tertiary pediatric medical
center before vaccine introduction. Eur J Pediatr. 2006;165(4):273–4.
22. OECD. Health at a Glance: Europe 2014. 2014. http://www.oecd-ilibrary.org/
docserver/download/8114211e.pdf?expires=1478253883&id=id&accname=
guest&checksum=BC6D5B6C3A1FCD87E416D170DA4E09CD.
23. Boelle PY, Hanslik T. Varicella in non-immune persons: incidence,
hospitalization and mortality rates. Epidemiol Infect. 2002;129(3):599–606.
24. Brisson M, Edmunds WJ, Law B, Gay NJ, Walld R, Brownell M, et al.
Epidemiology of varicella zoster virus infection in Canada and the United
Kingdom. Epidemiol Infect. 2001;127(2):305–14.
25. Thomas SL, Minassian C, Ganesan V, Langan SM, Smeeth L. Chickenpox and risk
of stroke: a self-controlled case series analysis. Clin Infect Dis. 2014;58(1):61–8.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Widgren et al. BMC Infectious Diseases  (2016) 16:666 Page 8 of 8
